IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DANIELLE JARRARD SHELNUT

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1841698867
CMS profile
9982769
Location
GAINESVILLE, GA

General Payments · PY2021–2024

$3,184.39

  • Reported across 179 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$930.45

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Gastroenterology GA All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $930.45 53

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $210.88 17
Ardelyx, Inc. $111.73 5
Salix Pharmaceuticals, a division of Bausch Health US, LLC $98.07 5
GENZYME CORPORATION $76.97 3
Lilly USA, LLC $70.97 3
Phathom Pharmaceuticals, Inc. $62.61 3
Takeda Pharmaceuticals U.S.A., Inc. $54.52 3
AIMMUNE THERAPEUTICS, INC. $50.51 3
Madrigal Pharmaceuticals $34.27 2
Janssen Biotech, Inc. $33.76 2
PFIZER INC. $33.11 2
Regeneron Healthcare Solutions, Inc. $20.51 1
Ipsen Biopharmaceuticals, Inc $20.46 1
INTERCEPT PHARMACEUTICALS, INC. $18.75 1
BOSTON SCIENTIFIC CORPORATION $18.72 1
Merck Sharp & Dohme Corporation $14.61 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $462.54 27
PY2022 $629.95 36
PY2023 $1,161.45 63
PY2024 $930.45 53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $13.03 01/11/2024 Food and Beverage Undisputed 01/23/2026 1106081337 CMS
ABBVIE INC. $0.70 01/11/2024 Food and Beverage Undisputed 01/23/2026 1106081339 CMS
ABBVIE INC. $17.53 01/23/2024 Food and Beverage Undisputed 01/23/2026 1106081341 CMS
ABBVIE INC. $19.33 02/01/2024 Food and Beverage Undisputed 01/23/2026 1106081343 CMS
ABBVIE INC. $12.42 02/27/2024 Food and Beverage Undisputed 01/23/2026 1106081345 CMS
ABBVIE INC. $18.63 03/02/2024 Food and Beverage Undisputed 01/23/2026 1106081347 CMS
ABBVIE INC. $6.65 03/15/2024 Food and Beverage Undisputed 01/23/2026 1106081349 CMS
ABBVIE INC. $1.72 03/27/2024 Food and Beverage Undisputed 01/23/2026 1106081351 CMS
ABBVIE INC. $1.71 03/27/2024 Food and Beverage Undisputed 01/23/2026 1106081353 CMS
ABBVIE INC. $16.85 04/16/2024 Food and Beverage Undisputed 01/23/2026 1106081355 CMS
ABBVIE INC. $13.69 05/07/2024 Food and Beverage Undisputed 01/23/2026 1106081357 CMS
ABBVIE INC. $14.27 06/17/2024 Food and Beverage Undisputed 01/23/2026 1106081359 CMS
ABBVIE INC. $16.14 08/05/2024 Food and Beverage Undisputed 01/23/2026 1106081361 CMS
ABBVIE INC. $14.71 09/10/2024 Food and Beverage Undisputed 01/23/2026 1106081363 CMS
ABBVIE INC. $13.32 10/07/2024 Food and Beverage Undisputed 01/23/2026 1106081365 CMS
ABBVIE INC. $12.97 10/23/2024 Food and Beverage Undisputed 01/23/2026 1106081367 CMS
ABBVIE INC. $17.21 11/06/2024 Food and Beverage Undisputed 01/23/2026 1106081369 CMS
AIMMUNE THERAPEUTICS, INC. $14.31 02/06/2024 Food and Beverage Undisputed 01/23/2026 1147016707 CMS
AIMMUNE THERAPEUTICS, INC. $19.68 05/14/2024 Food and Beverage Undisputed 01/23/2026 1146984303 CMS
AIMMUNE THERAPEUTICS, INC. $16.52 10/25/2024 Food and Beverage Undisputed 01/23/2026 1146993447 CMS
Ardelyx, Inc. $13.07 04/18/2024 Food and Beverage Undisputed 01/23/2026 1146707620 CMS
Ardelyx, Inc. $14.42 05/03/2024 Food and Beverage Undisputed 01/23/2026 1146707622 CMS
Ardelyx, Inc. $28.39 08/20/2024 Food and Beverage Undisputed 01/23/2026 1146707624 CMS
Ardelyx, Inc. $23.34 10/07/2024 Food and Beverage Undisputed 01/23/2026 1146707626 CMS
Ardelyx, Inc. $32.51 12/03/2024 Food and Beverage Undisputed 01/23/2026 1146707628 CMS
Boston Scientific Corporation $18.72 07/04/2024 Food and Beverage Undisputed 01/23/2026 1092396726 CMS
GENZYME CORPORATION $23.82 04/02/2024 Food and Beverage Undisputed 01/23/2026 1139877449 CMS
GENZYME CORPORATION $24.43 06/10/2024 Food and Beverage Undisputed 01/23/2026 1139877463 CMS
GENZYME CORPORATION $28.72 10/29/2024 Food and Beverage Undisputed 01/23/2026 1139877529 CMS
Intercept Pharmaceuticals, Inc. $18.75 02/12/2024 Food and Beverage Undisputed 01/23/2026 1113632420 CMS
Ipsen Biopharmaceuticals, Inc $20.46 09/17/2024 Food and Beverage Undisputed 01/23/2026 1091988495 CMS
Janssen Biotech, Inc. $15.35 02/13/2024 Food and Beverage Undisputed 01/23/2026 1078540111 CMS
Janssen Biotech, Inc. $18.41 07/16/2024 Food and Beverage Undisputed 01/23/2026 1078539127 CMS
Lilly USA, LLC $18.79 02/07/2024 Food and Beverage Undisputed 01/23/2026 1136132326 CMS
Lilly USA, LLC $25.11 03/21/2024 Food and Beverage Undisputed 01/23/2026 1136136372 CMS
Lilly USA, LLC $27.07 09/26/2024 Food and Beverage Undisputed 01/23/2026 1136144271 CMS
Madrigal Pharmaceuticals $17.98 10/23/2024 Food and Beverage Undisputed 01/23/2026 1144182287 CMS
Madrigal Pharmaceuticals $16.29 11/19/2024 Food and Beverage Undisputed 01/23/2026 1144182289 CMS
Merck Sharp & Dohme LLC $14.61 01/17/2024 Food and Beverage Undisputed 01/23/2026 1141812953 CMS
PFIZER INC. $17.15 10/31/2024 Food and Beverage Undisputed 01/23/2026 1131130894 CMS
PFIZER INC. $15.96 12/05/2024 Food and Beverage Undisputed 01/23/2026 1131099506 CMS
Phathom Pharmaceuticals, Inc. $25.64 03/01/2024 Food and Beverage Undisputed 01/23/2026 1151125098 CMS
Phathom Pharmaceuticals, Inc. $19.50 04/04/2024 Food and Beverage Undisputed 01/23/2026 1151125100 CMS
Phathom Pharmaceuticals, Inc. $17.47 06/14/2024 Food and Beverage Undisputed 01/23/2026 1151125102 CMS
Regeneron Healthcare Solutions, Inc. $20.51 10/24/2024 Food and Beverage Undisputed 01/23/2026 1114170080 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.67 03/06/2024 Food and Beverage Undisputed 01/23/2026 1153458597 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $22.38 05/13/2024 Food and Beverage Undisputed 01/23/2026 1153535484 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $22.16 06/06/2024 Food and Beverage Undisputed 01/23/2026 1153485765 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.73 07/24/2024 Food and Beverage Undisputed 01/23/2026 1153534670 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.13 11/13/2024 Food and Beverage Undisputed 01/23/2026 1153416793 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.59 01/26/2024 Food and Beverage Undisputed 01/23/2026 1137674465 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.12 03/26/2024 Food and Beverage Undisputed 01/23/2026 1137674467 CMS
Takeda Pharmaceuticals U.S.A., Inc. $19.81 08/28/2024 Food and Beverage Undisputed 01/23/2026 1137674469 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.